Page 5 - Development Contact News Today

 ABP-671 effective at lowering serum uric acid, the cause of gout JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience, a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, announced today that it will present final dated data from its Phase 2a clinical trial of its s...

KBRA releases research that discusses recent litigation between aircraft lessors and their insurance companies over the loss of assets stranded in Russia due to Western sanctions in the aftermath of

Joint effort will optimize manufacturing protocols to expand access to critical cancer therapies for more patients Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and

/PRNewswire/ -- Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories...

/PRNewswire/ -- Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories...

Press release content from Business Wire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Biofluidica today announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive...

/PRNewswire/ -- Biofluidica today announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive...

Live video webcast with moderated roundtable with members of the Melzi leadership team and surgical Key Opinion Leaders on Wednesday, June 8th at 11:00 AM ETRENO, NV / ACCESSWIRE / May 31, 2022 / Melzi

31.05.2022 - Live video webcast with moderated roundtable with members of the Melzi leadership team and surgical Key Opinion Leaders on Wednesday, June 8th at 11:00 AM ETRENO, NV / ACCESSWIRE / May 31, 2022 / Melzi Surgical (Melzi or the Company), a surgical ...